Merck KGaA (XTER:MRK)
€ 144.65 2.95 (2.08%) Market Cap: 61.61 Bil Enterprise Value: 69.14 Bil PE Ratio: 22.54 PB Ratio: 2.15 GF Score: 88/100

Q3 2021 Merck KGaA Earnings Call Transcript

Nov 11, 2021 / 01:00PM GMT
Release Date Price: €205 (-0.73%)
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the third quarter 2021. (Operator Instructions)

We now hand you over to Mr. Constantin Fest, Head of Investor Relations, who will lead you to today's conference. Please go ahead, sir.

Constantin Fest;Belen Garijo
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Thank you, Tracy. Very warm welcome, dear ladies and gentlemen, to this Q3 2021 results call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck. And I'm delighted to have here with me today, Belen Garijo, Group CEO; as well as Marcus Kuhnert, Group CFO. Also joining for the Q&A of this session today are Matthias Heinzel, CEO of Life Science; as well as Peter Guenter, CEO of Healthcare; and Kai Beckmann, CEO of Electronics.

In the next few minutes, we'd like to run you through the key slides of this presentation and then directly start the Q&A. Having said this, I'd like to now hand over to Belen to kick off the presentation. Over to you, Belen.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot